AU1445295A - Vitamin d3 analogues and pathway to mediate disorders - Google Patents
Vitamin d3 analogues and pathway to mediate disordersInfo
- Publication number
- AU1445295A AU1445295A AU14452/95A AU1445295A AU1445295A AU 1445295 A AU1445295 A AU 1445295A AU 14452/95 A AU14452/95 A AU 14452/95A AU 1445295 A AU1445295 A AU 1445295A AU 1445295 A AU1445295 A AU 1445295A
- Authority
- AU
- Australia
- Prior art keywords
- analogues
- vitamin
- pathway
- mediate disorders
- mediate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17356193A | 1993-12-23 | 1993-12-23 | |
US24938594A | 1994-05-25 | 1994-05-25 | |
PCT/US1994/014870 WO1995017197A1 (en) | 1993-12-23 | 1994-12-23 | Vitamin d3 analogues and pathway to mediate disorders |
US249385 | 2000-11-16 | ||
US173561 | 2005-07-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1445295A true AU1445295A (en) | 1995-07-10 |
Family
ID=26869286
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU14452/95A Abandoned AU1445295A (en) | 1993-12-23 | 1994-12-23 | Vitamin d3 analogues and pathway to mediate disorders |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0737070A4 (en) |
JP (1) | JPH09507079A (en) |
AU (1) | AU1445295A (en) |
CA (1) | CA2179288A1 (en) |
WO (1) | WO1995017197A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MA26481A1 (en) * | 1997-04-21 | 2004-12-20 | Hoffmann La Roche | ARYLSECOCHOLADIAN DERIVATIVES |
WO1998051663A2 (en) * | 1997-05-16 | 1998-11-19 | F. Hoffmann-La Roche Ag | 3-epi compounds of vitamin d3 and uses thereof |
EP1891944A1 (en) | 2006-07-24 | 2008-02-27 | Association pour la recherche à l'IGBMC (ARI) | Use of Vitamin D3 agonist in a mammalian model for atopic diseases and of Vitamin D3 antagonists for the treatment of atopic diseases |
CN114269348A (en) * | 2019-08-22 | 2022-04-01 | 工业技术和生物技术公司 | Hormone D (vitamin D) and its derivatives for the treatment and prevention of cancer |
CN111830157B (en) * | 2020-07-17 | 2022-02-25 | 大连美创药业有限公司 | Gas chromatography detection method for synthesizing eldecalcitol intermediate |
CN115850142A (en) * | 2022-11-25 | 2023-03-28 | 甘肃皓天医药科技有限责任公司 | Synthesis method of 7Z vitamin D compound |
-
1994
- 1994-12-23 JP JP7517631A patent/JPH09507079A/en not_active Ceased
- 1994-12-23 CA CA002179288A patent/CA2179288A1/en not_active Abandoned
- 1994-12-23 AU AU14452/95A patent/AU1445295A/en not_active Abandoned
- 1994-12-23 EP EP95906111A patent/EP0737070A4/en not_active Withdrawn
- 1994-12-23 WO PCT/US1994/014870 patent/WO1995017197A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP0737070A4 (en) | 1999-03-17 |
WO1995017197A1 (en) | 1995-06-29 |
EP0737070A1 (en) | 1996-10-16 |
JPH09507079A (en) | 1997-07-15 |
CA2179288A1 (en) | 1995-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6484896A (en) | Inline skateboard | |
AU4240093A (en) | Sports simulator | |
AU7436396A (en) | Glider chair | |
AU5010793A (en) | Human interleukin-13 | |
EP0859619A4 (en) | Multiple vitamin supplement composition | |
IL120843A0 (en) | Vitamin D3 analogs and their uses | |
IL105029A0 (en) | Vitamin d3 analogues | |
AU1306997A (en) | Pharmaceutical compositions with vitamin d analogues | |
AU5911994A (en) | Oral formulations of ubidecarenone in the form of capsules | |
AU3720193A (en) | Hydroisoindolines and hydroisoquinolines as psychotropic drugs | |
AU7017894A (en) | Solid cosmetics having moisturizing effect | |
AU2036297A (en) | Topical formulations of aciclovir | |
AU4014193A (en) | Chair | |
AU3553393A (en) | Toy glider | |
AU1445295A (en) | Vitamin d3 analogues and pathway to mediate disorders | |
AU4238093A (en) | Novel retinol derivatives and uses thereof | |
AU5737494A (en) | Human thrombospondin-4 | |
AU7227494A (en) | Inhalator | |
IL120844A0 (en) | Fluorinated vitamin D3 analogs and their uses | |
AU2152192A (en) | Self-drilling hollow rivet | |
AU6305696A (en) | Benzylhydroxylamines and intermediates used to prepare them | |
AU5112193A (en) | Chair | |
AU4975393A (en) | Improvements relating to earrings | |
AU7318994A (en) | Thf-gamma2 analogs and pharmaceutical compositions comprising them | |
AU1185297A (en) | Threaded fastener |